Sort
39,280 grants matching “leukemia”
BET bromodomain inhibition as targeted therapy in acute myeloid leukemia
$557,762Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2016 · CA
BET bromodomain inhibition as targeted therapy in acute myeloid leukemia
$557,762Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2017 · CA
BET bromodomain inhibition as targeted therapy in acute myeloid leukemia
$557,762Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2015 · CA
A Drug Delivery Strategy for Targeted Therapy of Chronic Lymphocytic Leukemia
$557,760Christoph Rader · Scripps Florida · R01 · FY2019 · CA
A novel population of PLZF+CD8+ regulatory T cells: phenotype and function
$557,738Vipin Kumar · University Of California, San Diego · R56 · FY2020 · AI
Role of IKAROS in the Biology and Therapy of High-Risk Precursor B-Cell Leukemia
$557,731Richard A. Van Etten · University Of California-Irvine · R01 · FY2015 · CA
GENETIC EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA
$557,717Nicola J Camp · University Of Utah · R01 · FY2016 · CA
Escape from CAR T surveillance through lineage plasticity
$557,374Patricia A Ernst · University Of Colorado Denver · R01 · FY2025 · CA
Tsepamo Plus: Expanded Congenital Abnormalities Surveillance with an Emulated Clinical Trial to Evaluate Weight Impact on Birth Outcomes for Newer ART Regimens
$557,311Roger L Shapiro · Harvard School Of Public Health · P01 · FY2022 · HD
MATH INTERVENTION FOR CHILDREN WITH LEUKEMIA
$557,157University Of Arizona · R01 · FY2003 · NR
Molecular Digital CytoImaging for Leukemia Drug Screening
$557,147Tothu Q Vu · Oregon Health & Science University · R01 · FY2022 · CA
Predictors of Myelodysplastic Syndrome in Minnesota
$557,106Jenny N. Poynter · University Of Minnesota · R01 · FY2019 · CA
CHILDHOOD LEUKEMIA AND ENVIRONMENTAL EXPOSURES
$557,089University Of California Berkeley · R01 · FY2003 · ES
Abnormal Stem Cell Trafficking in IM
$557,056Ronald Hoffman · Icahn School Of Medicine At Mount Sinai · P01 · FY2015 · CA
Improving CAR-T efficacy against solid tumors by expanding lymph node reservoirs of âstem-likeâ CAR-T cells
$557,041Shivani Srivastava · Fred Hutchinson Cancer Center · R37 · FY2024 · CA
Preclinical Testing of PI3K Inhibitors for Vestibular Schwannomas
$556,980Cristina Maria Fernandez-Valle · University Of Central Florida · R01 · FY2022 · DC
Chromatin assembly and formaldehyde toxicity
$556,894Chunyuan Jin · New York University School Of Medicine · R01 · FY2022 · ES
Pathology Resource Network
$556,874Carl D Morrison · Roswell Park Cancer Institute Corp · P30 · FY2010 · CA
Targeting B7-H3 in ovarian cancer
$556,817Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
Backtracking Leukemia-Typical Somatic Alterations in Cord Blood at Single-cell Resolution
$556,796Logan G Spector · University Of Minnesota · R01 · FY2023 · CA
Increased sensitivity of minimal residual disease monitoring using peripheral blood in pediatric patients with acute lymphoblastic leukemia
$556,708Rolf Muller · Biofluidica, Inc · R44 · FY2020 · CA
Transcription Factor Induced Reprogramming
$556,704Konrad Hochedlinger · Massachusetts General Hospital · R01 · FY2016 · HD
Immunotherapy of low grade lymphoid malignancies
$556,675Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
Adoptive Transfer of Donor Tregs Specific Against Host Alloantigens for Presentio
$556,530Joseph A Pidala · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2017 · HL
Define the oncogenic role of METTL3 in the pathogenesis of chronic lymphocytic leukemia
$556,211Lili Wang · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA